Sorafenib with interferon alfa-2b as first-line treatment of advanced renal carcinoma: a phase II study of the Southwest Oncology Group (Q38431094)
Jump to navigation
Jump to search
scientific article published on August 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sorafenib with interferon alfa-2b as first-line treatment of advanced renal carcinoma: a phase II study of the Southwest Oncology Group |
scientific article published on August 2007 |
Statements
1 reference
Sorafenib with interferon alfa-2b as first-line treatment of advanced renal carcinoma: a phase II study of the Southwest Oncology Group (English)
1 reference
Southwest Oncology Group
1 reference
Christopher W Ryan
1 reference
Bryan H Goldman
1 reference
Primo N Lara
1 reference
Philip C Mack
1 reference
Tomasz M Beer
1 reference
Catherine M Tangen
1 reference
Dianne Lemmon
1 reference
Chong-Xian Pan
1 reference
Harry A Drabkin
1 reference
E David Crawford
1 reference
1 August 2007
1 reference
1 reference
Identifiers
1 reference